PFE - GSK Pfizer decline as CDC advisors recommend narrower age range for RSV shots
2024-06-26 16:38:07 ET
More on GSK, Pfizer
- Wall Street Lunch: Pfizer Looks To Take Next Step In Weight-Loss Drugs
- Pfizer: Seriously Undervalued At Peak Pessimism
- Pfizer Stock: The Reversal Should Keep Going
- Pfizer CEO reveals new weight loss drug mechanism in the works
- Lilly, Novo Nordisk to dominate weight loss therapy market: SA Investing Summit